- 全部删除
 
您的购物车当前为空
Secukinumab 是一种完全人源化的单克隆抗 IL-17A 抗体,是一个被美国食品和药物管理局批准用于治疗中度至重度斑块型银屑病的抗体。

为众多的药物研发团队赋能,
让新药发现更简单!
Secukinumab 是一种完全人源化的单克隆抗 IL-17A 抗体,是一个被美国食品和药物管理局批准用于治疗中度至重度斑块型银屑病的抗体。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 1,330  | In stock | |
| 5 mg | ¥ 3,370  | In stock | |
| 10 mg | ¥ 4,890  | In stock | |
| 25 mg | ¥ 7,680  | In stock | |
| 50 mg |  待询   | In stock | 
Secukinumab 相关产品
| 产品描述 | Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.  | 
| 别名 | 苏金单抗, 司库奇尤单抗 | 
| 分子量 | 147.93 kDa | 
| CAS No. | 1229022-83-6 | 
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
评论内容